Analytical Data
-
Gene name
CPA6
- Application
-
Alternative Names
CPA6; CPAHCarboxypeptidase A6; EC 3.4.17.-
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N4T0
-
Expression Region
130-437aa
-
Molecular Weight
52.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CPA6 (Carboxypeptidase A6) is a member of the carboxypeptidase family, which plays a crucial role in various biological processes, including protein catabolism and cellular signaling. Research into CPA6 has gained interest due to its potential involvement in neurodevelopmental disorders and its association with metabolic pathways. Recent studies suggest that CPA6 may influence the processing of neuropeptides and neurotransmitters, thus affecting neural communication and behavior. Additionally, CPA6 has been implicated in certain diseases, including some types of cancer, where its expression levels may vary significantly. Understanding the structure, function, and regulatory mechanisms of CPA6 is essential for elucidating its role in health and disease. Advances in protein engineering and structural biology techniques have enabled researchers to explore the nuanced interactions of CPA6 with other biomolecules, providing insights into its enzymatic functions and potential therapeutic applications. As the scientific community continues to unravel the multifaceted roles of CPA6, it holds promise as a target for innovative treatments and diagnostics in various disorders linked to its dysregulation.
